Ensign Peak Advisors, Inc Charles River Laboratories International, Inc. Transaction History
Ensign Peak Advisors, Inc
- $51.2 Billion
- Q1 2025
A detailed history of Ensign Peak Advisors, Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 14,699 shares of CRL stock, worth $2.22 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,699
Previous 16,122
8.83%
Holding current value
$2.22 Million
Previous $2.98 Million
25.67%
% of portfolio
0.0%
Previous 0.01%
Shares
20 transactions
Others Institutions Holding CRL
# of Institutions
648Shares Held
55MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$922 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$768 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$647 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$361 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$294 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.68B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...